Ticker > Company >

Max Healthcare Inst share price

Max Healthcare Institute Ltd.

NSE: MAXHEALTH BSE: 543220 SECTOR: Hospital & Healthcare Services  1.76 L   667   165

1153.45
-16.75 (-1.43%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 1179.9

Today's Low

₹ 1148

52 Week High

₹ 1314.3

52 Week Low

₹ 873.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

112142.61 Cr.

Enterprise Value

112227.94 Cr.

No. of Shares

97.22 Cr.

P/E

157.29

P/B

13.45

Face Value

₹ 10

Div. Yield

0.13 %

Book Value (TTM)

₹  85.74

CASH

416.5 Cr.

DEBT

501.83 Cr.

Promoter Holding

23.74 %

EPS (TTM)

₹  7.33

Sales Growth

13.76%

ROE

8.88 %

ROCE

11.84%

Profit Growth

2.01 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.76%
3 Year14.48%
5 Year114.06%

Profit Growth

1 Year2.01%
3 Year28.36%
5 Year198.97%

ROE%

1 Year8.88%
3 Year9.58%
5 Year6.09%

ROCE %

1 Year11.84%
3 Year10.77%
5 Year7.74%

Debt/Equity

0.0614

Price to Cash Flow

187.53

Interest Cover Ratio

20.5644

CFO/PAT (5 Yr. Avg.)

1.14648999204342

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 23.74 0.00
Mar 2025 23.74 0.00
Dec 2024 23.74 0.00
Sep 2024 23.74 0.00
Jun 2024 23.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 28.3563079490194% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 20.5644.
  • The Company has been maintaining an effective average operating margins of 26.8825276815615% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -140.6137 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.14648999204342.

 Limitations

  • The company has shown a poor revenue growth of 14.4792928003083% for the Past 3 years.
  • Company has contingent liabilities of 2012.53 Cr.
  • The company is trading at a high PE of 157.29.
  • The company is trading at a high EV/EBITDA of 91.4989.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 621.39 686.11 697.4 658.7 694.02
Total Expenditure 423.32 461.44 461.36 484.09 506.31
Operating Profit 198.07 224.67 236.04 174.61 187.71
Other Income 42.87 133.51 92.01 98.15 79.85
Interest 7.64 7.85 23.47 9.43 9.25
Depreciation 30.14 32.18 32.77 36.1 35.43
Exceptional Items 0 0 -73.63 0 0
Profit Before Tax 203.16 318.15 198.18 227.23 222.88
Tax 49.02 86.85 59.94 49.84 56.85
Profit After Tax 154.14 231.3 138.24 177.39 166.03
Adjusted EPS (Rs) 1.59 2.38 1.42 1.82 1.71

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1030.78 1775.36 1904.66 2341.36 2663.6
Total Expenditure 869.88 1340.3 1321.5 1581.99 1831.3
Operating Profit 160.9 435.06 583.16 759.37 832.3
Other Income 106.51 136.32 145.1 273.89 367.63
Interest 112.45 58.93 51.91 51.66 48.39
Depreciation 90.75 111.96 113.21 116.64 131.19
Exceptional Items -210.67 0 0 0 -73.63
Profit Before Tax -146.46 400.49 563.14 864.96 946.72
Tax 17.99 68.97 -131.17 177.7 245.65
Net Profit -164.45 331.52 694.31 687.26 701.07
Adjusted EPS (Rs.) -1.7 3.42 7.15 7.07 7.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 965.95 969.61 970.92 971.91 972.14
Total Reserves 4973.48 5341.77 6071.19 6708.85 7317.21
Borrowings 316.92 382.4 428.85 313.44 469.87
Other N/C liabilities 611.45 818.75 508.19 562.63 624.6
Current liabilities 275.15 299.23 441.18 512.04 583.4
Total Liabilities 7142.95 7811.76 8420.33 9068.87 9967.22
Assets
Net Block 2988.96 4493.02 4484.64 4716.87 4866.16
Capital WIP 8.15 14.06 57.03 128.51 240.32
Intangible WIP 0.19 46.19 45.82 106.53 36.63
Investments 2379.3 1447.01 1474.74 1915.36 2613.71
Loans & Advances 802.31 963.03 852.84 1106.93 1288.98
Other N/C Assets 2.19 136.01 69.21 67.91 93.33
Current Assets 961.85 712.44 1436.05 1026.76 828.09
Total Assets 7142.95 7811.76 8420.33 9068.87 9967.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -146.46 400.49 563.14 864.96 946.72
Adjustment 309.87 77.13 61.49 -62.81 -113.79
Changes in Assets & Liabilities 37.92 12.57 160.09 -40.5 -53.6
Tax Paid 23.14 -42.83 -88.25 -148.69 -181.32
Operating Cash Flow 224.47 447.36 696.47 612.96 598.01
Investing Cash Flow -104.87 -669.65 301.69 -805.64 -873.26
Financing Cash Flow 412.41 -161.48 -54.47 -245.91 -28.81
Net Cash Flow 532.01 -383.77 943.69 -438.59 -304.06

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 23.74 23.74 23.74 23.74 23.74
abhay soi 23.74 23.73 23.73 23.73 23.73
aditya soi 0.01 0.01 0.01 0.01 0.01
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 76.26 76.26 76.26 76.26 76.26
axis mutual fund - - - 1.02 1.01
canara robeco mutual fund... 1.71 1.61 1.29 1.28 1.28
government of singapore 7.21 6.71 5.92 5.69 5.07
government pension fund g... - 1.18 1.12 1.09 1.14
hdfc life insurance compa... - - - 1.01 1.06
kotak funds - india midca... 1.01 1.05 1.06 1.06 1.06
llp 0.08 0.08 0.09 0.08 0.08
monetary authority of sin... 1.48 1.53 1.38 1.49 1.43
motilal oswal mutual fund... - - 1.05 1.36 1.39
new world fund inc 6.02 6.15 6.11 5.33 5.33
nps trust- a/c icici prud... - - - - 1.04
sbi mutual fund 2.37 2.35 2.37 1.74 1.54
smallcap world fund, inc 4.43 4.43 4.22 3.55 3.31
vanguard total internatio... - 1.06 1.07 1.08 1.10
hdfc mutual fund 3.03 2.44 1.84 1.76 -
kotak mutual fund - - - 1.08 -
fidelity investment trust... - 1.10 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research Way 2 Wealth
Research Geojit
Research IDBI Capital
Research NuvamaWealth
Research Nuvama Wealth
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY25
Concall Q3FY25
Concall Q3FY24
Concall Q3FY24
Concall Q3FY21
Concall Q2FY21
Concall Q1FY26
Concall Q1FY25
Concall Q1FY23
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY23
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY21

Company News

Max Healthcare Inst Stock Price Analysis and Quick Research Report. Is Max Healthcare Inst an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Max Healthcare Inst. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Max Healthcare Inst has a PE ratio of 156.766486663394 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Max Healthcare Inst has ROA of 7.3657% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Max Healthcare Inst has a Current ratio of 1.4194.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Max Healthcare Inst has a ROE of 8.8839%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Max Healthcare Inst has a Debt to Equity ratio of 0.0614 which means that the company has low proportion of debt in its capital.

  • Sales growth: Max Healthcare Inst has reported revenue growth of 13.7629% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Max Healthcare Inst for the current financial year is 31.2471842619012%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Max Healthcare Inst is Rs 1.5 and the yield is 0.1305%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Max Healthcare Inst is Rs 7.3332. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Max Healthcare Inst in Ticker for free. Also, one can get the intrinsic value of Max Healthcare Inst by using Valuation Calculators, which are available with a Finology ONE subscription. 

Max Healthcare Inst FAQs

Q1. What is Max Healthcare Inst share price today?
Ans: The current share price of Max Healthcare Inst is Rs 1149.6.

Q2. What is the market capitalisation of Max Healthcare Inst?
Ans: Max Healthcare Inst has a market capitalisation of Rs 111768.30010776 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Max Healthcare Inst?
Ans: The PE ratio of Max Healthcare Inst is 156.766486663394 and the P/B ratio of Max Healthcare Inst is 13.4082121800591, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Max Healthcare Inst share?
Ans: The 52-week high share price of Max Healthcare Inst is Rs 1314.3, and the 52-week low share price of Max Healthcare Inst is Rs 873.5.

Q5. Does Max Healthcare Inst pay dividends?
Ans: Currently, Max Healthcare Inst pays dividends. Dividend yield of Max Healthcare Inst is around 0.1305%.

Q6. What are the face value and book value of Max Healthcare Inst shares?
Ans: The face value of Max Healthcare Inst shares is Rs 10, while the book value per share of Max Healthcare Inst is around Rs 85.7385. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Max Healthcare Inst?
Ans: Max Healthcare Inst has a total debt of Rs 501.83 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Max Healthcare Inst?
Ans: The ROE of Max Healthcare Inst is 8.8839% and ROCE of Max Healthcare Inst is 11.8376%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Max Healthcare Inst a good buy for the long term?
Ans: The Max Healthcare Inst long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Max Healthcare Inst undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Max Healthcare Inst appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Max Healthcare Inst’s financials?
Ans: You can review Max Healthcare Inst’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Max Healthcare Inst
X